PAOG PAO GROUP INC

PAOG Confirms Farmersville Hemp Brand CBD Product Line Development For PURA

PAOG Confirms Farmersville Hemp Brand CBD Product Line Development For PURA

Sandusky, OH, Jan. 06, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed the development of a line of CBD nutraceutical products for Puration, Inc. (OTC Pink: PURA) is underway.

PURA has updated its business model over the course of the last year and is now focusing on the development of a hemp business cooperative under the brand name Farmersville Hemp. 

PURA has established its new business model to build an industrial hemp business with 3 sources of revenue – education, branding and partnerships.

PURA recently announced signing its first Farmersville Hemp clients that will in turn contribute to the company’s 2022 revenue objectives.

.

Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). 

PAOG is developing both and nutraceutical treatments for humans based on this intellectual property.

PAOG and PURA are partnering on the development of CBD infused products to be marketed under the Farmersville Hemp brand name.  Look for details on the Farmersville CBD products to be announced later this month.

PAOG currently markets its own independent line of CBD nutraceutical products under its “RX” label available for sale on North American Cannabis Inc.’s (OTC Pink: USMJ) ecommerce site .

For more information on Puration, visit 

Learn more about PAOG at .

Disclaimer:

This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.

For More Information Contact:

Puration, Inc.

Brian Shibley,



(800) 861-1350

Jim DiPrima

888-272-6472



EN
06/01/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PAO GROUP INC

 PRESS RELEASE

PAOG Expects Increased Visibility For Its CBD Nutraceuticals From USMJ...

PAOG Expects Increased Visibility For Its CBD Nutraceuticals From USMJ Ecommerce Campaign Sandusky, OH, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to enjoy increased market visibility for its RX Branded CBD Nutraceuticals resulting from the announced earlier today. PAOG currently markets its own independent line of CBD nutraceutical products under its “RX” label available for sale on North American Cannabis Inc.’s (OTC Pink: USMJ) ecommerce site . PAOG is also working with Puration, Inc. (OTC Pink: PURA) on the develop...

 PRESS RELEASE

PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceut...

PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development Sandusky, OH, Feb. 01, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today republished its 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy.  The update was originally released on Friday, January 27th, 2022. The update is included in its entirety below: PAO Group, Inc. is an emerging cannabis and CBD company targeting growth via two tracks – pharmaceutical and nutraceutical. The Company is developing a cannabis extract-based therapy to tre...

 PRESS RELEASE

PAOG Publishes 2022 Strategic Update

PAOG Publishes 2022 Strategic Update Sandusky, OH, Jan. 28, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today released a 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy. The update is included in its entirety below: PAO Group, Inc. is an emerging cannabis and CBD company targeting growth via two tracks – pharmaceutical and nutraceutical. The Company is developing a cannabis extract-based therapy to treat various respiratory diseases and illnesses including COPD.  Recent independent has confirmed PAOG’s previous conclusion...

 PRESS RELEASE

PAOG Cites Research On Hemp Compounds Effectiveness Treating Covid To ...

PAOG Cites Research On Hemp Compounds Effectiveness Treating Covid To Advance Pharmaceutical Development Sandusky, OH, Jan. 25, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today cited recently published information on research indicating CBDA and CBGA, compounds found in hemp, “block a critical step in the process the [Covid] virus uses to infect people” (). “The two compounds were identified during a chemical screening by researchers at the Linus Pauling Institute at Oregon State University. The compounds bind to spike proteins found on the virus and blocked the spike ...

 PRESS RELEASE

PAOG Confirms Farmersville Hemp Brand CBD Product Line Development For...

PAOG Confirms Farmersville Hemp Brand CBD Product Line Development For PURA Sandusky, OH, Jan. 06, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed the development of a line of CBD nutraceutical products for Puration, Inc. (OTC Pink: PURA) is underway. PURA has updated its business model over the course of the last year and is now focusing on the development of a hemp business cooperative under the brand name Farmersville Hemp.  PURA has established its new business model to build an industrial hemp business with 3 sources of revenue – education, brandi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch